Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

nicholas laboratories - dimeticone aluminium hydroxide magnesium hydroxide - gel

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

john wyeth & brother limited - aluminium hydroxide magnesium hydroxide dimeticone, activated - gel

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

nicholas laboratories - dimeticone aluminium hydroxide-magnesium carbonate gel magnesium hydroxide - tablets

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

seton products ltd - magnesium oxidum leve aluminium hydroxide dimethicone 350 - oral suspension

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - esomeprazole magnesium dihydrate, quantity: 21.69 mg - capsule, enteric - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); triethyl citrate; titanium dioxide; mannitol; hypromellose; gelatin; stearoyl macrogolglycerides; maize starch; polysorbate 80; purified talc; iron oxide yellow; sucrose; diacetylated monoglycerides; purified water; dimeticone 350; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - gastro-oesophageal reflux disease (gord),? treatment of erosive reflux oesophagitis,? long-term management of patients with healed oesophagitis to prevent relapse,? symptomatic treatment of gastro-oesophageal reflux disease (gord),patients requiring nsaid therapy,? short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy.,? healing of gastric ulcers associated with non-steroidal anti-inflammatory,drug nsaid (non-selective and cox-2 selective) therapy,? prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug nsaid (non-selective and cox-2 selective) therapy in patients at risk.,prevention of rebleeding of gastric or duodenal ulcers following treatment with iv esomeprazole solution by intravenous infusion.,pathological hypersecretory conditions including zollinger-ellison syndrome and idiopathic hypersecretion,in combination with appropriate antibiotics for:,? healing of duodenal ulcer associated with helicobacter pylori,? eradication of helicobacter pylori in patients with active or healed peptic ulcer

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - esomeprazole magnesium dihydrate, quantity: 43.37 mg - capsule, enteric - excipient ingredients: maize starch; dimeticone 350; gelatin; purified water; hypromellose; sucrose; methacrylic acid - ethyl acrylate copolymer (1:1); titanium dioxide; polysorbate 80; triethyl citrate; purified talc; iron oxide yellow; diacetylated monoglycerides; mannitol; stearoyl macrogolglycerides; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - gastro-oesophageal reflux disease (gord),? treatment of erosive reflux oesophagitis,? long-term management of patients with healed oesophagitis to prevent relapse,? symptomatic treatment of gastro-oesophageal reflux disease (gord),patients requiring nsaid therapy,? short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy.,? healing of gastric ulcers associated with non-steroidal anti-inflammatory,drug nsaid (non-selective and cox-2 selective) therapy,? prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug nsaid (non-selective and cox-2 selective) therapy in patients at risk.,prevention of rebleeding of gastric or duodenal ulcers following treatment with iv esomeprazole solution by intravenous infusion.,pathological hypersecretory conditions including zollinger-ellison syndrome and idiopathic hypersecretion,in combination with appropriate antibiotics for:,? healing of duodenal ulcer associated with helicobacter pylori,? eradication of helicobacter pylori in patients with active or healed peptic ulcer

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

ssl international plc - aluminium hydroxide dimethicone 350 - tablets

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

boots healthcare new zealand limited - aluminium hydroxide gel dried 500mg; dimeticone 250mg - tablet - 500mg/250mg - active: aluminium hydroxide gel dried 500mg dimeticone 250mg

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

boots healthcare new zealand limited - aluminium hydroxide gel dried 50mg; dimeticone 50mg - oral granules - 50 mg - active: aluminium hydroxide gel dried 50mg dimeticone 50mg

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

ayrton saunders (ireland) limited - dimeticone 350; zinc oxide - cutaneous spray, suspension - 12.5%w/w + 1.04 percent weight/weight - zinc products